Your request to link to rcsb for Cholinesterase

• 2Q7J: the wild type androgen receptor ligand binding domain bound with testosterone and a tif2 box 3 coactivator peptide 740-753 (10.1074/JBC.M703268200 )
• 2Q7K: the androgen receptor prostate cancer mutant h874y ligand binding domain bound with testosterone and an ar 20-30 peptide (10.1074/JBC.M703268200 )
• 2Q7I: the wild type androgen receptor ligand binding domain bound with testosterone and an ar 20-30 peptide (10.1074/JBC.M703268200 )
• 2Q7L: the androgen receptor prostate cancer mutant h874y ligand binding domain bound with testosterone and a tif2 box3 coactivator peptide 740-753 (10.1074/JBC.M703268200 )
• 5JKW: human placental aromatase cytochrome p450 (cyp19a1) complexed with testosterone (10.1016/J.JSBMB.2018.02.009 )
• 4J6D: the 2.4 a crystal structure of cyp154c5 from nocardia farcinica in complex with testosterone (10.1107/S1399004714019129 )
• 6LY4: the crystal structure of the bm3 mutant lg-23 in complex with testosterone (10.1002/ANIE.202003139 )
• 2YLO: targeting the binding function 3 site of the androgen receptor through in silico molecular modeling (10.1021/JM201098N )
• 2YLQ: targeting the binding function 3 site of the androgen receptor through in silico molecular modeling (10.1021/JM201098N )
• 2YLP: targeting the binding function 3 site of the androgen receptor through in silico molecular modeling (10.1021/JM201098N )
• 1I9J: testosterone complex structure of the recombinant monoclonal wild type anti-testosterone fab fragment (10.1074/JBC.M105579200 )
• 1VPO: crystal structure analysis of the anti-testosterone fab in complex with testosterone (10.1074/JBC.M208392200 )
• 3UZZ: crystal structure of 5beta-reductase (akr1d1) e120h mutant in complex with nadp+ and delta4-androstenedione (10.1074/JBC.M111.338780 )
• 1JTV: crystal structure of 17beta-hydroxysteroid dehydrogenase type 1 complexed with testosterone
• 7CL8: testosterone-bound structure of cyp154c2 from streptomyces avermitilis in an closed conformation
• 2AM9: crystal structure of human androgen receptor ligand binding domain in complex with testosterone (10.1110/PS.051905906 )
• 1AFS: recombinant rat liver 3-alpha-hydroxysteroid dehydrogenase (3-alpha-hsd) complexed with nadp and testosterone (10.1016/S0969-2126(97)00234-7 )
• 6A7J: testerone bound cyp154c4 from streptomyces sp. atcc 11861 (10.1111/FEBS.14729 )
• 5L94: the 2.25 a crystal structure of cyp109e1 from bacillus megaterium in complex with testosterone (10.1111/FEBS.13911 )
• 3KDM: crystal structure of human anti-steroid fab 5f2 in complex with testosterone (10.1002/JMR.1039 )
• 3ZQT: targeting the binding function 3 site of the androgen receptor through in silico molecular modeling (10.1021/JM201098N )
• 6MDQ: crystal structure of equine serum albumin in complex with testosterone (10.1039/C8SC04397C )
• 5OG9: the bm3 mutant wifi-wc heme domain in complex with testosterone
• 4HLW: targeting the binding function 3 (bf3) site of the human androgen receptor through virtual screening. 2. development of 2-((2- phenoxyethyl) thio)-1h-benzoimidazole derivatives. (10.1021/JM3015712 )
• 3BUR: crystal structure of delta(4)-3-ketosteroid 5-beta-reductase in complex with nadp and testosterone. resolution: 1.62 a. (10.1074/JBC.M801778200 )
• 2YHD: human androgen receptor in complex with af2 small molecule inhibitor (10.1021/JM200532B )
• 1Q13: crystal structure of rabbit 20alpha hyroxysteroid dehydrogenase in ternary complex with nadp and testosterone (10.1016/J.JMB.2004.03.035 )
• 1J96: human 3alpha-hsd type 3 in ternary complex with nadp and testosterone (10.1074/JBC.M105610200 )
• 6HGL: crystal structure of alpha1-antichymotrypsin variant newbg-iii: a new binding globulin in complex with testosterone (10.1016/J.JSB.2019.05.006 )